{
  "docId": "019de072-ece7-71de-8eba-0df52639d987",
  "docSlug": "f4caf3b83872d8591c78c133c07757ed",
  "documentTitle": "BenevolentAI | Investor Presentation Deck | 19 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 19,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "Includes a breakdown of UC severity levels (64%, 31%, 5%) and a summary of the drug's mechanism and target patient population.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-ece7-71de-8eba-0df52639d987/13",
  "deckHref": "/decks/019de072-ece7-71de-8eba-0df52639d987",
  "deckJsonHref": "/decks/019de072-ece7-71de-8eba-0df52639d987.json",
  "deckAnchorHref": "/decks/019de072-ece7-71de-8eba-0df52639d987#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.42,
        "x": 0.53,
        "y": 0.16
      },
      "kind": "callout",
      "text": "BEN-8744: Best-in-class, oral, peripherally restricted potent and selective drug for the treatment of Moderate-Severe Ulcerative Colitis",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ce58b18f-9dba-4c68-aca4-57cc1110dc5a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.05,
        "y": 0.64
      },
      "kind": "diagram",
      "text": "Ulcerative Colitis breakdown: 64% Mild-moderate, 31% Moderate-severe, 5% Severe-fulminant",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e67172d3-3c7b-493d-a511-0582d5beb204",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.05,
        "y": 0.28
      },
      "kind": "list",
      "text": "A chronic, lifelong disease... Efficacy - 20-40% of Moderate-severe patients do not respond... Safety - Treatments have many side effects... High unmet need for an alternative oral small molecule...",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b1d986c-ae6e-4f0f-9fa4-a38b7f5a5dd3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.55,
        "y": 0.3
      },
      "kind": "list",
      "text": "Phosphodiesterase 10 (PDE10) was identified... Using our Molecular Design expertise... BEN-8744 is expected to provide... BEN-8744 will target Moderate and Severe UC/IBD patients...",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e413666d-641b-4cb3-93b1-2ac6b8e99971",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.05,
        "y": 0.16
      },
      "kind": "paragraph",
      "text": "Affects 0.4% US population(1), 1.7 million patients in 7MM(2), forecast $7.8bn market by 2026(3)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7c7d9ad4-91a1-4e2c-85d4-09dfe0a1fbbc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source (1) and (2):GlobalData: Ulcerative Colitis, Global Drug Forecast and Market Analysis to 2026; (3)Evaluate Pharma: Gastro-intestinal, Inflammatory bowel disease (IBD), Ulcerative colitis, Worldwide Overview (report 17th Sep 2021)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe00fb17-edc5-4563-a20f-a467e2e3c891",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "BEN-8744 - Ulcerative Colitis (UC)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d4108916-7bdb-4730-b731-0e6ea6332ee6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "04ffd2a9-733a-4432-b2ef-ed4bfa3d9b31",
      "evidence": "A chronic, lifelong disease... Efficacy - 20-40% of Moderate-severe patients do not respond... Safety - Treatments have many side effects... High unmet need for an alternative oral small molecule...",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 15,
      "from": 10,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "b60aafe0-945b-4485-b373-af4183f36f2b",
      "evidence": "BEN-2293 and BEN-8744 progress",
      "position": 1,
      "objective": "Showcase quick wins and big bets in pipeline",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}